Related Experiment Video

Updated: Oct 17, 2026

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation
10:35

Assessment of Antibody-based Drugs Effects on Murine Bone Marrow and Peritoneal Macrophage Activation

Published on: December 26, 2017

Intravenous immunoglobulin in very severe childhood Guillain-Barré syndrome

S C Singhi1, M Jayshree, P Singhi

  • 1Pediatric Intensive Care Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India. medinst@pgi.chd.nic.in

Annals of Tropical Paediatrics
|February 26, 2000
PubMed

Insights

Intravenous immunoglobulin (IVIG) therapy significantly improves outcomes for children with severe Guilain-Barré syndrome (GBS). IVIG reduces respiratory support needs, shortens intensive care unit stays, and accelerates recovery and ambulation in pediatric GBS patients.

Area of Science:

  • Pediatric Neurology
  • Immunology
  • Critical Care Medicine

Background:

  • Guillain-Barré syndrome (GBS) is a rare autoimmune disorder affecting the peripheral nervous system.
  • Very severe GBS in children can lead to quadriparesis and respiratory muscle weakness, necessitating intensive care.
  • Standard supportive and respiratory care are crucial for managing severe GBS.

Purpose of the Study:

  • To evaluate the efficacy of intravenous immunoglobulin (IVIG) therapy in children with very severe GBS.
  • To assess the impact of IVIG on respiratory support requirements, intensive care unit (ICU) stay, and long-term functional outcomes.
  • To compare outcomes between children treated with IVIG and those receiving standard care.

Main Methods:

  • A prospective study of 22 children with very severe GBS receiving IVIG (0.4 g/kg/day for 5 days) alongside supportive care.
  • A retrospective control group of 11 children with similar GBS severity and age, receiving only supportive care.
  • Comparison of muscle power recovery, ICU length of stay, need for mechanical ventilation, and functional status at 1 and 3 months post-treatment.

Main Results:

  • The IVIG group showed significantly earlier onset of muscle power recovery (14.8 days vs. 20.9 days).
  • Length of PICU stay was significantly shorter in the IVIG group (20.5 days vs. 50.5 days).
  • More children in the IVIG group achieved functional improvement (72.7% vs. 18%) and independent ambulation (68% vs. 36%) compared to controls.

Conclusions:

  • Intravenous immunoglobulin therapy markedly improves outcomes in children with very severe GBS.
  • IVIG therapy reduces the need for endotracheal intubation and mechanical ventilation.
  • IVIG shortens ICU stays and promotes earlier ambulation in pediatric GBS patients.

More Related Videos

Intralymphatic Immunotherapy and Vaccination in Mice07:33

Intralymphatic Immunotherapy and Vaccination in Mice

Published on: February 2, 2014

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation08:04

Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation

Published on: July 9, 2014

Related Concept Videos

Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...